SCHEMBL20205459

SCHEMBL20205459

CC1(C)c2cc3c(cc2-c2c1cc(-c1ccc4ccccc4c1)c1oc4ccccc4c21)C(C)(C)c1cc(-c2ccc4ccccc4c2)c2oc4ccccc4c2c1-3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.38
▸ ALOX5 P09917 1/20 0.34
▸ GSTP1 P09211 1/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ ALK Q9UM73 2/20 0.34
▸ MTOR P42345 1/20 0.34
▸ MIF P14174 1/20 0.33
▸ LPL P06858 1/20 0.33
▸ LIPG Q9Y5X9 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24649889 0.96 GPR84 (0.35) GPR84ALOX5GSTP1CYP1A2CYP2C9
SCHEMBL20205642 0.94 PGR (0.37) GPR84ALOX5ALKLPLLIPG
SCHEMBL23351761 0.91 GPR84 (0.36) GPR84ALOX5GSTP1CYP1A2CYP2C9
SCHEMBL20205524 0.91 GPR84 (0.35) GPR84ALOX5GSTP1CYP1A2CYP2C9
SCHEMBL20927728 0.90 GPR84 (0.33) GPR84ALOX5CYP1A2CYP2C9CYP1A1
SCHEMBL20205622 0.88 TDP1 (0.32) GPR84ALOX5CYP1A2CYP1A1ALK
SCHEMBL20205623 0.88 PRKDC (0.34) ALOX5NPC1RAB9AALKPRKDC
SCHEMBL20205632 0.88 PRKDC (0.36) ALOX5CYP1A2CYP2C9CYP1A1CYP1B1
SCHEMBL20205625 0.88 CYP1A1 (0.34) ALOX5CYP1A2CYP2C9CYP1A1CYP1B1
SCHEMBL20205638 0.88 TDP1 (0.37) ALOX5CYP1A2CYP1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND GPR84 3257/4885ALOX5 354/4885GSTP1 1356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback